ThisAgreementismadeandenteredintobyandbetweenthefollowingpartiesonOctober1st,本合同發(fā)生時間于：2015101PartyA:ShanghaiEthypharmPharmaceuticals甲方：愛的發(fā)制藥Address：Room1805-1806,Ciro’sPlaza,No.388NanjingRoad(W),經(jīng)營地址：市西路388號仙樂斯廣場1805-1806 傳真PartyB:HenanRuianPharmaceuticalCo.,

Address:No.1718SouthZijinshan,GuanchengDistrictZhengzhou1718 傳真PartyC:HefeiKangbaishiPharmaceuticalAddress：No.453,FeicuiGarden,FeicuiRoad,HefeiEconomicandTechnologicalDevelopmentZone,AnhuiProvince經(jīng)營地址：省合肥市經(jīng)濟技術(shù)開發(fā)區(qū)翡翠路翡翠花園453 傳真鑒于甲乙雙方 緩釋膠囊 獨 Whereas,PartyAandPartyBsignedon anationwideexclusiveagencyagreementinrespectof鑒于甲乙雙方 緩釋膠囊 獨 省非獨 協(xié)議（以下簡稱“合同二）執(zhí)行事宜予以說明。為保證兩份合同的順 將ScopeofTheSuccessFee(includingtaxes)PolicyasstipulatedinAgreementIIshallbeshown ent1ofthisUponmutualagreementbetweenPartyAandPartyB,theSuccessFeePolicyinasstipulatedinAgreementIIshallbeperformedtoPartyCuntiltheexpirationofthevalidityperiodoftheAgreementII.Thepurchasingvolumeduringthecontractualperiodshallbecalculatedasfollows:additionadditionof(1)theityaspurchasedbyPartyCfromPartyAduringtheperiodJanuaryof2015toSeptemberof2015,and(2)theityaspurchasedbyPartyCParty duringtheperiodfromOctoberof2015toDecemberof2015.WhereinthetytyaspurchasedbyPartyCfromPartyBshallbesubmittedtoPartyAbywayofcommercialflow(whichshallbeaffixedwithcommercialcompany2015120159月丙方向甲方采購的盒裝數(shù)PartyAagreesthatsuccessfeecanbepaidbywayofgoodsinsteadofPartyAshallpayPartyBthesuccessfeebeforePartyBpaystoPartyThevalidtermofthisAgreementshallcommencefromOctober1st,2015toDecember31st,201510120151231EachofPartyA,PartyBandPartyCmayterminatethisAgreementatanytimeDecember31st,2015,andundersuchcircumstance,PartyAshallonlyberesponsiblefortherelatedservicebeforetheeffectivedateoftermination.甲、乙、丙在2015年12月31日前均可在任何時間終止本合同，在這種情況下TermsandPartyA,PartyBandPartyCherebyexecutedthisAgreementuponmutualnegotiation,whichshalltakeeffectandbeperformedfromthedateOctober1st,2015,withtherelatedproductcatalogattachedheretoasAttaent1. PartyA:ShanghaiEthypharmPharmaceuticalsCo.甲方：愛的發(fā)制藥PartyB:HenanRuianPharmaceuticalCo.,PartyC:HefeiKangbaishiPharmaceuticalPinipl:委托人t：附件一：返利達標(biāo)政策Attaent在本協(xié)議所述年度內(nèi)（20151120151231日），Withintheyear(onJanuary1,2015toDecember31,2015)hereofPartyCmayenjoythefollowingsuccessfees藥品通用名PharmaceuticalsGeneric商品名Commodity劑型Dosage規(guī)格SuccessFees(including非諾緩釋膠囊緩釋膠VolumesConditionsduringtheSuccessFee(amountperboxfromfirstboxincluding少于或等于最低年采購量50000]BeloworEqualtotheMinimumAnnualPurchases,[50000]nosuccessEqualorMorethan[50001]不超過或等于[80000]Nomorethanorequal[